In 2024, the merger and acquisition activities in the medical device manufacturing industry showed unprecedented vitality. This is not only the result of enterprises’ pursuit of technological innovation, market expansion and resource optimization and integration, but also reflects the continued rise in global medical and health needs. Industry giants represented by Johnson & Johnson, Stryker and Mindray Medical have significantly promoted the rapid development of the industry through large-scale cross-border mergers and acquisitions. At the same time, the unique “A acquisition A” model of China’s Science and Technology Innovation Board provides a new way for domestic companies to grow rapidly. Thanks to the Chinese government’s introduction of a number of policy measures to promote mergers and acquisitions, such as the “M&A 6″, industry mergers and acquisitions have received more friendly policy support.
Looking ahead, with the continued expansion of the global medical and health market and the acceleration of technological innovation, mergers and acquisitions in the medical device manufacturing industry are expected to become more frequent and become the preferred strategy for domestic and foreign companies to expand their scale and enhance their competitiveness. Through mergers and acquisitions, companies can not only quickly acquire key technologies and expand their international market share, but also effectively optimize their product portfolio. In the increasingly fierce market competition environment, maintaining technological innovation capabilities and high sensitivity to market changes has become a common challenge faced by all participants. For investors, a deep understanding of industry development trends and policy trends will help seize the valuable investment opportunities brought about by this wave of mergers and acquisitions.
So far, there have been 31 mergers and acquisitions in the medical device field at home and abroad in 2024, with a total amount of more than US$38 billion. The largest amount of mergers and acquisitions was naturally the acquisition of Shockwave Medical by the giant Johnson & Johnson at a sky-high price of US$13.1 billion.
In addition, other medical device companies are also accelerating their international layout and expanding overseas markets through mergers and acquisitions and self-built production capacity.
October 2022: Gongdong Medical announced the acquisition of the core assets of Trademark Plastics Inc., a US disposable medical consumables company, for US$45 million.
March 2024: Zhende Medical established its first factory in Kenya, Africa, which is the first production base of China’s medical device industry in Kenya.
April 2024: Kangzhong Medical completed the acquisition of 30% equity of ISDI LIMITED, a British high-performance CMOS-X-ray detector and CMOS image sensor company.
April 2024: Aojin Medical acquired HT Dental, a German oral implant company, and officially entered the implant field.
May 2024: Weili Medical announced that it will set up a subsidiary and build a production base in Mexico, with a total investment of US$10 million.
July 26, 2024: Tigermed completed the acquisition of Japanese CRO company Medical Edge, further strengthening its business capabilities in the Japanese market.
Post time: Dec-02-2024
